top of page
News, Events and Updates
Search
Anavex Appoints Experienced Pharma Executive as Vice President of Clinical Operations
Aug 6, 2014
Anavex Achieves Key Milestone as it Secures cGMP Manufacturing for Drug Candidate Trial Supplies
Jul 20, 2014
Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor
Jul 16, 2014
ANAVEX 3-71 Highly Effective and Disease-Modifying Against All Major Alzheimer's Hallmarks
Jul 13, 2014
Anavex Announces Report Expanding Opportunity for Therapeutic Application of Anavex Compounds
Jun 29, 2014
M1 Muscarinic Agonists and a Multipotent Activator of Sigma1/M1 Muscarinic Receptors
Jun 9, 2014
Anavex Awarded New U.S. Patent
Jun 3, 2014
Anavex Appoints Dr. Abraham Fisher to Scientific Advisory Board
May 27, 2014
Anavex Reports That New Data Confirms Calcium Target Over-Expression May Be Involved in Causing AD
May 21, 2014
Anavex Provides Business Update Including Clinical Trial Plans for ANAVEX PLUS in AD
May 14, 2014
Anavex Strengthens Scientific Advisory Board with Clinical Trial Expert
May 11, 2014
39
40
41
42
43
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
